Iaconisi Giorgia Natalia, Mancini Rachele, Ricci Vincenzo, Donati Danilo, Sconza Cristiano, Marvulli Riccardo, Ranieri Maurizio, Megna Marisa, Varrassi Giustino, Della Tommasa Simone, Bernetti Andrea, Capobianco Loredana, Farì Giacomo
Department of Biological and Environmental Sciences and Technologies, University of Salento (DiSTeBA), 73100 Lecce, Italy.
Department of Translational Biomedicine and Neuroscience (DiBraiN), Aldo Moro University, 70125 Bari, Italy.
Clin Pract. 2024 Dec 19;14(6):2737-2758. doi: 10.3390/clinpract14060216.
BACKGROUND/OBJECTIVES: Osteoporosis causes a bone mass reduction and often determines acute and chronic pain. Understanding the biochemical and neurophysiological mechanisms behind this pain is crucial for developing new, effective rehabilitative and therapeutic approaches. This systematic review synthesizes recent advances in muscle-bone interactions and molecular pathways related to osteoporosis-associated pain.
We carried out a systematic review including studies published from 2018 to 2024 using PubMed, Scopus, clinicaltrials.gov and Cochrane Library. The Cochrane Collaboration tool was used to assess bias risk. The review adhered to PRISMA guidelines and is registered with PROSPERO (CRD42024574456); Results: Thirteen studies were included. It emerged that osteoporosis causes progressive bone loss due to disruptions in biochemical processes and muscle-bone interactions. This condition is also closely associated with the development of pain, both acute and chronic. Key findings include the role of the miR-92a-3p/PTEN/AKT pathway and the impact of muscle-bone disconnection on bone health. Mechanotransduction is critical for bone maintenance. Effective pain management and rehabilitation strategies include physical therapy and physical exercise, yoga, Pilates, and cognitive behavioral therapy (CBT); they all improve pain relief and functional outcomes by enhancing muscle strength, flexibility, and balance. Pharmacological options such as NSAIDs, opioids, and new agents like SHR-1222, along with surgical interventions like percutaneous vertebroplasty, offer additional pain reduction, especially when included in individualized rehabilitation projects; Conclusions: This review highlights advancements in understanding osteoporotic pain mechanisms and identifies promising treatments. Integrating targeted therapies and rehabilitation strategies can enhance patients' pain relief.
背景/目的:骨质疏松症会导致骨量减少,并常常引发急慢性疼痛。了解这种疼痛背后的生化和神经生理机制对于开发新的有效康复和治疗方法至关重要。本系统评价综合了与骨质疏松症相关疼痛的肌肉-骨骼相互作用和分子途径的最新进展。
我们进行了一项系统评价,纳入了2018年至2024年发表在PubMed、Scopus、clinicaltrials.gov和Cochrane图书馆上的研究。使用Cochrane协作工具评估偏倚风险。该评价遵循PRISMA指南,并在PROSPERO(CRD42024574456)上注册;结果:纳入了13项研究。结果表明,骨质疏松症由于生化过程和肌肉-骨骼相互作用的破坏而导致进行性骨质流失。这种情况也与急慢性疼痛的发生密切相关。主要发现包括miR-92a-3p/PTEN/AKT途径的作用以及肌肉-骨骼脱节对骨骼健康的影响。机械转导对骨骼维持至关重要。有效的疼痛管理和康复策略包括物理治疗和体育锻炼、瑜伽、普拉提和认知行为疗法(CBT);它们都通过增强肌肉力量、灵活性和平衡来改善疼痛缓解和功能结果。非甾体抗炎药、阿片类药物等药物选择以及SHR-1222等新药,连同经皮椎体成形术等手术干预措施,可提供额外的疼痛缓解,尤其是纳入个体化康复项目时;结论:本评价强调了在理解骨质疏松性疼痛机制方面的进展,并确定了有前景的治疗方法。整合靶向治疗和康复策略可以增强患者的疼痛缓解。